Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06612203 |
| Title | Clinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer (WIN-B) |
| Acronym | WIN-B |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | MedSIR |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hospital Universitari Dexeus | Barcelona | Spain | Details | |||
| Hospital Universitario Clínico San Cecilio de Granada | Granada | Spain | Details | |||
| Hospital Beata María Ana | Madrid | Spain | Details | |||
| Hospital Universitario Virgen de la Victoria | Málaga | Spain | Details | |||
| Hospital Arnau de Vilanova de Valencia | Valencia | Spain | Details | |||
| Beatson West of Scotland Cancer Center | Glasgow | United Kingdom | Details | |||
| Barts Health NHS Trust | London | United Kingdom | Details |